営業利益・営業利益率の推移
| 年度 |
営業利益 |
営業利益率 |
| 2025/3 |
-261,627 |
- |
| 2024/3 |
-234,773 |
- |
| 2023/3 |
-177,080 |
- |
| 2022/3 |
-118,314 |
- |
| 2021/3 |
-79,955 |
- |
| 2020/3 |
-56,198 |
|
| 2019/3 |
-30,946 |
|
|
（単位：千ドル）
|
2019/3
|
2020/3
|
2021/3
|
2022/3
|
2023/3
|
2024/3
|
2025/3
|
|
研究開発費
|
22,173
|
38,761
|
56,754
|
79,545
|
126,527
|
174,963
|
189,447
|
|
営業費用
|
30,946
|
56,198
|
79,955
|
118,314
|
177,080
|
234,773
|
261,627
|
|
営業利益
|
-30,946
|
-56,198
|
-79,955
|
-118,314
|
-177,080
|
-234,773
|
-261,627
|
|
経常（税引前）利益
|
-
|
-
|
-
|
-
|
-173,996
|
-215,386
|
-246,829
|
|
法人税等合計
|
-
|
-
|
-
|
-
|
300
|
400
|
500
|
|
実効税率（％）
|
-
|
-
|
-
|
-
|
-0.2
|
-0.2
|
-0.2
|
|
純利益
|
30,834
|
-52,625
|
-80,870
|
-118,036
|
-174,284
|
-215,794
|
-247,297
|
|
一株あたり利益
|
-
|
-
|
-
|
-2.26
|
-2.99
|
-3.24
|
-3.07
|
|
希薄化後一株あたり利益
|
-
|
-
|
-
|
-2.26
|
-2.99
|
-3.24
|
-3.07
|
|
EBITDA
|
|
|
-78,255
|
-116,214
|
-174,680
|
-232,073
|
-258,127
|